Efficacy and Safety of Sacituzumab Tirumotecan (SKB264) in Combination With Toripalimab in Patients With Initially Unresectable Stage III NSCLC
Clinical trial NCT06706219 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06706219
- Sponsor
- Hunan Province Tumor Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-10
- Primary completion
- 2028-11-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.